In the last year, many IDEXX Laboratories, Inc. (NASDAQ:IDXX) insiders sold a substantial stake in the company which may have sparked shareholders' attention. Knowing whether insiders are buying ...

We recently compiled a list of the 8 Best Pet Stocks to Buy According to Billionaires. In this article, we are going to take ...

Conestoga Capital Advisors stated the following regarding IDEXX Laboratories, Inc. (NASDAQ:IDXX) in its Q4 2024 investor letter: “IDEXX Laboratories, Inc. (NASDAQ:IDXX) is the industry leader ...

According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025. It is expected to grow at a compound annual growth rate (CAGR) of 5.48% ...

IDEXX Laboratories has a 52 week low of $398.50 and a 52 week high of $562.25. The company has a current ratio of 1.31, a quick ratio of 0.95 and a debt-to-equity ratio of 0.28. Insiders Place ...

IDEXX Laboratories, Inc. has a 52 week low of $398.50 and a 52 week high of $548.88. The stock has a market capitalization of $34.21 billion, a PE ratio of 39.42, a P/E/G ratio of 3.41 and a beta ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in ...

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and ...

President Trump in his address to Congress touted receiving a letter from Ukrainian President Volodymyr Zelensky earlier Tuesday amid an effort to smooth ties between Washington and Kyiv following ...